Topic Review
Urinary Tract Infections during the COVID-19 Pandemic
The landscape of management of urinary tract infections (UTI) is changing rapidly. The COVID-19 pandemic draws the attention to the SARS-CoV-2 management with a subsequent reduced attention on bacterial infections. The COVID-19 diffusion containing procedures, such as use of facemasks and handwashing, have reduced spreading of bacteria and bacterial lung infections.
  • 2.6K
  • 21 Mar 2022
Topic Review
Urinary Tract Infections
Urinary tract infections (UTIs) affect any part of the urinary tract and may spread through the urinary tract towards the urethra, bladder and even the kidneys and they are associated with an increase in morbidity and mortality. UTIs may be resolved spontaneously or treated with antibiotics. However, regular use of antibiotics is related to nephrotoxicity and  produces changes in the intestinal flora, alter immunity and metabolism, and finally, gut bacteria become a reservoir of genes for resistance to antibiotics. Regarding this concern, a new group of molecules called drug conjugates have been proposed as an alternative or a complement to de use of just antibiotics such as a new adjuvant in UTIs therapy called Itxasol©.
  • 2.0K
  • 11 Oct 2021
Topic Review
Urinary Tract Infection and Microbiome
Urinary tract infection is one of the most common bacterial infections and can cause major burdens, not only to individuals but also to an entire society. Urinary tract infection is not only caused by invading uropathogenic bacteria but also by changes to the uromicrobiome milieu, and interactions with other microbial communities can also contribute. 
  • 241
  • 08 Jun 2023
Topic Review
Urinary Peptide and Proteomic Biomarkers in CKD
Biomarker development, improvement, and clinical implementation in the context of kidney disease have been a central focus of biomedical research. Only serum creatinine and urinary albumin excretion are well-accepted biomarkers in kidney disease. With their known blind spot in the early stages of kidney impairment and their diagnostic limitations, there is a need for better and more specific biomarkers. With the rise in large-scale analyses of the thousands of peptides in serum or urine samples using mass spectrometry techniques, hopes for biomarker development are high. Advances in proteomic research have led to the discovery of an increasing amount of potential proteomic biomarkers and the identification of candidate biomarkers for clinical implementation in the context of kidney disease management.
  • 182
  • 08 Jun 2023
Topic Review
Urinary Bladder Cancer
Urinary bladder cancer (UBC) is the most common malignancy of the urinary tract in humans, with an estimated global prevalence of 1.1 million cases over 5 years. Because of its high rates of recurrence and resistance to chemotherapy, UBC is one of the most expensive cancers to treat, resulting in significant health care costs.
  • 429
  • 28 Jan 2021
Topic Review
Urinary Biomarkers in Bladder Cancer
Extracellular vesicles (EVs) are small membrane vesicles released by all cells and involved in intercellular communication. Importantly, EVs cargo includes nucleic acids, lipids, and proteins constantly transferred between different cell types, contributing to autocrine and paracrine signaling. In recent years, they have been shown to play vital roles, not only in normal biological functions, but also in pathological conditions, such as cancer. In the multistep process of cancer progression, EVs act at different levels, from stimulation of neoplastic transformation, proliferation, promotion of angiogenesis, migration, invasion, and formation of metastatic niches in distant organs, to immune escape and therapy resistance. Moreover, as products of their parental cells, reflecting their genetic signatures and phenotypes, EVs hold great promise as diagnostic and prognostic biomarkers. Importantly, their potential to overcome the current limitations or the present diagnostic procedures has created interest in bladder cancer (BCa). Indeed, cystoscopy is an invasive and costly technique, whereas cytology has poor sensitivity for early staged and low-grade disease. Several urine-based biomarkers for BCa were found to overcome these limitations.
  • 895
  • 10 Oct 2020
Topic Review
Urinary Biomarkers for Early Diagnosis of Disease
Urinary biomarkers are molecules found in urine that can be used as indicators of certain diseases or health conditions. The presence or absence of these biomarkers can help in the early detection of diseases, allowing for timely intervention and treatment, improving patients outcomes.
  • 263
  • 19 Apr 2023
Topic Review
Uric Acid Oxidant/Antioxidant Paradox
Extracellular uric acid (UA) exhibits antioxidant properties by effectively scavenging free radicals in human plasma, but this benefit might be disturbed by the hydrophobic lipid layer of the cell membrane. In contrast, intracellular free oxygen radicals are produced during UA degradation, and superoxide is further enhanced by interacting with NADPH oxidase. This intracellular oxidative stress, together with inflammatory cytokines induced by UA, stimulates osteoclast bone resorption and inhibits osteoblast bone formation. UA also inhibits vitamin D production and thereby results in hyper-parathyroidism, which causes less UA excretion in the intestines and renal proximal tubules by inhibiting the urate transporter ATP-binding cassette subfamily G member 2 (ABCG2). 
  • 1.3K
  • 26 Aug 2021
Topic Review
Uric Acid in Heart Failure
UA is an independent predictor of mortality in acute and chronic HF, making it a significant prognostic factor in both settings. High serum levels have been also associated with an increased incidence of HF, thus expanding the clinical utility of UA. 
  • 497
  • 20 Feb 2021
Topic Review
Uric Acid Electroanalysis
Uric acid is a metabolic product that results from degradation of purines in the liver. Usually, uric acid is identified from biological fluids, human serum and urine through conventional methods, such as spectroscopy, chromatography, electrochemistry, membrane capillary electrophoresis and spectrophotometric methods, including uricase enzymatic reactions. Importantly, uric acid determination opens the possibility of early intervention in cases of hyperuricemia and preventing the degradation of renal function.
  • 517
  • 25 Jun 2023
  • Page
  • of
  • 1349
Video Production Service